in

Researchers find out why some lung tumors avoid immunotherapy, and learn how to predict this in advance

Researchers find out why some lung tumors avoid immunotherapy and how to predict it in advance
Graphical abstract. Credit: Cell Reports Medicine (2023). DOI: 10.1016/j.xcrm.2023.101006

The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy (ICB). This is the main conclusion of a study recently published in Cell Reports Medicine by…

Read the full post

Written by Editor

Lanvin Creative Director Exits Amid Brand Restructure

Lanvin Creative Director Exits Amid Brand Restructure

The must-read books that have millions of fans on BookTok

The must-read books and authors that have millions of fans on BookTok